The Current Shift In the Marketing Strategy Is Work By Multinational Pharmaceutical Companies. It Is Now High-End (Rather Than Adaptive) Development That Is Being Carried Out By Leading Companies. And, Increasingly, Other Companies Are Finding Themselves Competing Against, or Working With, New Innovation-Based Companies. My Study Focuses on the Processes and Outcomes of Globally Distributed Pharmaceutical Companies. This Article Will Present the Changing Marketing Strategies When a Pharma Company Shifts from Acute Base to Chronic Therapy Base. This Research Paper Will Also Give an Insight About Shift In Supply Chain Process and Customer and End-Customer Perception Which Is the Base of Formulation of Different Marketing Strategies.